Cargando…

Effect of prucalopride on symptoms of chronic constipation

BACKGROUND: Prucalopride is a 5-HT(4) receptor agonist with gastrointestinal prokinetic activities. This integrated analysis of data from three 12-week, double-blind trials evaluated the effect of prucalopride 2 mg q.d. on common constipation symptoms in women in whom laxatives had failed to provide...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tack, J, Stanghellini, V, Dubois, D, Joseph, A, Vandeplassche, L, Kerstens, R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BlackWell Publishing Ltd 2013
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4282451/ https://www.ncbi.nlm.nih.gov/pubmed/24106924 http://dx.doi.org/10.1111/nmo.12217

Ejemplares similares

Prucalopride Improves Bowel Function and Colonic Transit Time in Patients With Chronic Constipation: An Integrated Analysis
por: Emmanuel, Anton, et al.
Publicado: (2014)

Cost-effectiveness of prucalopride in the treatment of chronic constipation in the Netherlands
por: Nuijten, Mark J. C., et al.
Publicado: (2015)

Efficacy and Safety of Prucalopride in Chronic Constipation: An Integrated Analysis of Six Randomized, Controlled Clinical Trials
por: Camilleri, Michael, et al.
Publicado: (2016)

Efficacy and Safety of Prucalopride in Patients with Chronic Noncancer Pain Suffering from Opioid-Induced Constipation
por: Sloots, Cornelius E. J., et al.
Publicado: (2010)

A Review of the Cardiovascular Safety of Prucalopride in Patients With Chronic Idiopathic Constipation
por: Tack, Jan, et al.
Publicado: (2023)

Efficacy of Prucalopride for Chronic Idiopathic Constipation: An Analysis of Participants With Moderate to Very Severe Abdominal Bloating
por: Staller, Kyle, et al.
Publicado: (2022)

Effect of renal impairment on the pharmacokinetics of prucalopride: a single- dose open-label Phase I study
por: Smith, William B, et al.
Publicado: (2012)

Randomised clinical trial: the efficacy of prucalopride in patients with chronic intestinal pseudo-obstruction - a double-blind, placebo-controlled, cross-over, multiple n = 1 study
por: Emmanuel, A V, et al.
Publicado: (2012)

Prucalopride: the evidence for its use in the treatment of chronic constipation
por: Coremans, Georges
Publicado: (2008)

Patient considerations in the management of chronic constipation: focus on prucalopride
por: Shin, Andrea
Publicado: (2016)

Effect of Prucalopride on the Pharmacokinetics of Oral Contraceptives in Healthy Women
por: Van de Velde, Vera, et al.
Publicado: (2013)

Clinical Efficacy and Safety Profile of Prucalopride in Chronic Idiopathic Constipation
por: Tameez Ud Din, Asim, et al.
Publicado: (2019)

Response to letter: Balancing risks and benefits of prucalopride for the treatment of chronic constipation in Asians
por: Ke, M, et al.
Publicado: (2013)

Assessment of the cardiac safety of prucalopride in healthy volunteers: a randomized, double-blind, placebo- and positive-controlled thorough QT study
por: Mendzelevski, Boaz, et al.
Publicado: (2012)

Development of a population pharmacokinetic model of prucalopride in children with functional constipation
por: van Schaick, Erno, et al.
Publicado: (2016)

Cardiovascular Safety of Prucalopride in Patients with Chronic Constipation: A Multinational Population-Based Cohort Study
por: Gilsenan, Alicia, et al.
Publicado: (2019)

A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial to Evaluate the Efficacy, Safety, and Tolerability of Prucalopride in Men With Chronic Constipation
por: Yiannakou, Yan, et al.
Publicado: (2015)

Effect of Prucalopride in the Treatment of Chronic Constipation in Asian and Non-Asian Women: A Pooled Analysis of 4 Randomized, Placebo-controlled Studies
por: Ke, MeiYun, et al.
Publicado: (2014)

Prucalopride: A Recently Approved Drug by the Food and Drug Administration for Chronic Idiopathic Constipation
por: Mahajan, Rajiv
Publicado: (2019)

The PAC‐SYM questionnaire for chronic constipation: defining the minimal important difference
por: Yiannakou, Y., et al.
Publicado: (2017)

Role of Prucalopride in Treating Functional Constipation and Gastroparesis: A Systemic Review
por: Ali, Hassam, et al.
Publicado: (2021)

Role of prucalopride, a serotonin (5-HT(4)) receptor agonist, for the treatment of chronic constipation
por: Wong, Banny S, et al.
Publicado: (2010)

Different doses of prucalopride in treating chronic idiopathic constipation: a meta-analysis and Bayesian analysis
por: Yang, Tao, et al.
Publicado: (2021)

Current Opinion on Prucalopride in Gastroparesis and Chronic Constipation Treatment: A Focus on Patient Selection and Safety
por: Hong, Ji Taek
Publicado: (2021)

Prucalopride in the treatment of chronic constipation in patients from the Asia-Pacific region: a randomized, double-blind, placebo-controlled study
por: Ke, M, et al.
Publicado: (2012)

Use of Prucalopride for Chronic Constipation: A Systematic Review and Meta-analysis of Published Randomized, Controlled Trials
por: Sajid, Muhammad S, et al.
Publicado: (2016)

Diagnosis and treatment of chronic constipation – a European perspective
por: Tack, J, et al.
Publicado: (2011)

Effect of electroacupuncture versus prucalopride for severe chronic constipation: protocol of a multi-centre, non-inferiority, randomised controlled trial
por: Liu, Baoyan, et al.
Publicado: (2014)

The Effects of Prucalopride on Postoperative Ileus in Guinea Pigs
por: Park, Soo Jung, et al.
Publicado: (2013)

Effects of prucalopride on esophageal secondary peristalsis in humans
por: Yi, Chih-Hsun, et al.
Publicado: (2016)

Antipsychotics induced constipation in patients with mental disorders. treatment suggestion with prucalopride in refractory cases. case report and literature review
por: Mpouras, P., et al.
Publicado: (2022)

An Open-Label, Head to Head Comparison Study between Prucalopride and Lactulose for Clozapine Induced Constipation in Patients with Treatment Resistant Schizophrenia
por: Damodaran, Ishwary, et al.
Publicado: (2020)

Efficacy and safety analysis of prucalopride in refractory chronic constipation cases in a tertiary care hospital in Eastern India: A randomized, single-blind, placebo-controlled study
por: Dehury, Suhasini, et al.
Publicado: (2023)

Lower and Upper Gastrointestinal Symptoms Differ Between Individuals With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation
por: Shah, Eric D, et al.
Publicado: (2018)

Chronic constipation in the elderly: a primer for the gastroenterologist
por: De Giorgio, Roberto, et al.
Publicado: (2015)

Design of a phase 3, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of prucalopride in pediatric patients with functional constipation
por: Cuffari, Carmen, et al.
Publicado: (2023)

Review article: linaclotide for the management of irritable bowel syndrome with constipation
por: Layer, P, et al.
Publicado: (2014)

The Effect of Prucalopride on the Completion Rate and Polyp Detection Rate of Colon Capsule Endoscopies
por: Deding, Ulrik, et al.
Publicado: (2022)

In-hospital costs associated with chronic constipation in Belgium: a retrospective database study
por: Chevalier, P, et al.
Publicado: (2014)

Factors Predictive of Treatment-Emergent Adverse Events of Prucalopride: An Integrated Analysis of Four Randomized, Double-Blind, Placebo-Controlled Trials
por: Leelakusolvong, Somchai, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_fro9gnknnuv3thjq8djvom2847